Cadila receives USFDA approval for Acetazolamide ER


Zydus Cadila has received the final USFDA approval to market Acetazolamide ER Capsules. Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used to treat certain types of glaucoma (caused by increased ocular pressure) and to treat or prevent altitude sickness (acute mountain sickness). The drug is likely to be produced at its Moraiya manufacturing facility near Ahmedabad in Gujarat.

Company Profile : Cadila Healthcare Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.